A phase-1 healthy volunteer study of Sudo-286 as a topical treatment for psoriasis and other immune-mediated dermatologic diseases
Latest Information Update: 04 Dec 2024
At a glance
- Drugs SUDO 286 (Primary)
- Indications Psoriasis
- Focus Adverse reactions
Most Recent Events
- 04 Dec 2024 New trial record